News Highlights: Top Company News of the Day - Thursday at 3 PM ET

Dow Jones
25 Apr
 
Pepsi and Mountain Dew Depend on Imports. PepsiCo Says Tariffs Will Hurt Earnings. 
 

The maker of Doritos and Cheetos also cited a drop in consumer confidence caused by inflation and the global trade war.

 
Comcast Loses Broadband Customers, Takes Theme-Park Hit From L.A. Fires 
 

The company posted lower quarterly earnings, but found bright spots with its mobile-phone plans and Peacock streaming service.

 
Gold Bull Kaplan Lands 'Holy Grail' Deposit as Precious Metal Hits Records 
 

Billionaire investor Thomas Kaplan is nearing a long-held ambition: control of a big gold deposit in Alaska.

 
Procter & Gamble Cuts Fiscal-Year Guidance 
 

Procter & Gamble lowered its fiscal-year outlook after posting lower sales in the third quarter amid a challenging consumer environment.

 
American Airlines Pulls Full-Year Outlook on Concerns Over Travel Demand 
 

American Chief Executive Robert Isom says he is confident the airline can withstand uncertainty in the economy.

 
Jersey Mike's Hires New CEO After $8 Billion Sale 
 

Charlie Morrison, former Wingstop CEO, will lead the sandwich chain after its sale to Blackstone. Founder Peter Cancro remains board chairman.

 
UPS to Buy Canada's Andlauer Healthcare for $1.6 Billion 
 

United Parcel Service agreed to buy Canada's Andlauer Healthcare Group for roughly $1.6 billion in an effort to grow in healthcare transportation and logistics.

 
Nissan Expects Roughly $5 Billion Net Loss From Impairments, Restructuring Costs 
 

Nissan Motor estimated billions of dollars in net loss for the fiscal year ended March due to impairments and restructuring expenses.

 
Merck Cuts 2025 Outlook on Tariffs, Charges 
 

Merck's first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 adjusted earnings projection, partly to account for recently imposed tariffs.

 
Bristol Myers Squibb Shares Sink Despite Better-Than-Expected Earnings. The Future Is Cloudy. 
 

Bristol Myers sees revenue decline in its legacy drug portfolio due to competition and Medicare headwinds.

 
 

(END) Dow Jones Newswires

April 24, 2025 15:00 ET (19:00 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10